Source: MarketScreener

Destiny: AIM WINNERS & LOSERS: Destiny Pharma falls on plans to go private

(marketscreener.com) The following stocks are the leading risers and fallers on AIM on Monday. ---------- AIM - WINNERS ---------- Genedrive PLC, up 36% at 3.80 pence, 12-month range 1.21p-12.40p. receives breakthrough device designation from the US Food & Drug Administration for the Genedrive MT-RNR1 ID Kit. The kit is a rapid point-of-care test to screen infants...https://www.marketscreener.com/quote/stock/DESTINY-PHARMA-PLC-37788317/news/AIM-WINNERS-LOSERS-Destiny-Pharma-falls-on-plans-to-go-private-47380535/?utm_medium=RSS&utm_content=20240715

Read full article »
Annual Revenue
$5.0-25M
Employees
1-25
Chris Tovey's photo - CEO of Destiny

CEO

Chris Tovey

CEO Approval Rating

82/100

Read more